Acute and continuation risperidone monotherapy in bipolar mania: A 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol - Smulevich, A B; Khanna, S; Eerdekens, M (Eur Neuropsychopharmacol, 2005)
et al.